March 13, 2018: A short interview with Timo on Karveel’s research and antibiotic resistance on Dutch BNR Nieuwsradio: (starts at 12:00 min).

January 9, 2018: Congratulations to dr. Laurens Kleijn on successfully defending his doctoral thesis.

January 1, 2018: Karveel welcomes Laurens Kleijn as a full-time employee!

December 18, 2017: Karveel has been awarded an NWO Take-Off phase 2 loan, to be used to advance our lead compounds towards preclinical trials.

February 6, 2016: Synamp Pharmaceuticals B.V. (Karveel’s old name) is profiled in today’s issue of the “Financieele Dagblad”.

November 23, 2015: Karveel’s parent company Synamp Pharmaceuticals B.V. is the winner of the 2015 Fall edition of the “Venture Challenge”. The Venture Challenge is a national competition for biotech startups organised by LifeSciences@Work and carries a cash prize of €25,000.

September 1, 2015: Karveel is happy to announce the hiring of our first employee, Dr. Timo Koopmans.

August 1, 2015: Karveel’s first private financing round is complete. This funding will support preclinical validation of our lead compound(s) in various infection models with drug-resistant pathogens including MRSA and VRE.